3
Macrofocal multiple myeloma with frontal plasmacytoma Kamal Kant Sahu, 1 Pramod DA Kumar, 2 Uday Yanamandra, 1,3 Pankaj Malhotra 1 1 Departments of Hematology and Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India 2 Department of Internal Medicine, Post Graduate Institue of Medical Education and Research, Chandigarh, India 3 Department of Internal Medicine, Armed Forces Medical College, Pune, Maharashtra, India Correspondence to Dr Uday Yanamandra, [email protected] Accepted 8 May 2015 To cite: Sahu KK, Kumar PDA, Yanamandra U, et al. BMJ Case Rep Published online: [ please include Day Month Year] doi:10.1136/bcr-2015- 210759 DESCRIPTION A 27-year-old man presented with a 5-month history of left-sided forehead swelling. The patient had no other symptoms. Examination was unre- markable except for pallor and swelling of the left frontal bone displacing the orbit in a downward and outward direction ( gure 1A, B). The patient had normochromic normocytic anaemia (haemoglobin 8.7 g/dL) with normal total leucocyte count (3900/mL) and platelet count (200 000/mL). His renal parameters (urea 29 mg/dL, creatine 0.66 mg/dL) as well as serum calcium level (9.2 mg/dL) were normal. Positron emission tomog- raphy CT showed intense uorodeoxyglucose uptake in left frontal region accompanied by multiple lytic lesions ( gure 2AD). Fine-needle aspiration from forehead swelling was suggestive of plasmacytoma ( gure 3). Bone marrow showed 8% plasma cells. There was no paraproteinaemia, based on normal serum/urine protein electrophoresis and serum immunoxation. A serum β2-microglobulin (2.1 mg/ L) and serum free light chain study was normal. Diagnosis of macrofocal multiple myeloma (ISS-I, C-R-A+B+) was made. The patient received six cycles of chemotherapy (dexamethasone 40 mg weekly, thalidomide 100 mg daily) followed by thalidomide mainten- ance owing to nancial constraints and non- affordability for autologous haematopoietic stem cell transplantation. His forehead swelling disap- peared following three cycles ( gure 1C, D). Presence of extramedullary plasmacytoma (com- monly involving soft tissue, lungs, pleura, genito- urinary system and skull) is associated with poor outcome. 1 Macrofocal multiple myeloma is a dis- tinct entity (with multiple lytic lesions and no bone marrow involvement) with superior rates of sur- vival. 2 Orbital plasmacytomas are treated differently by various authors, using radiotherapy, local dexa- methasone injection or systemic chemotherapy. 3 Figure 1 (A) Frontal view showing protuberant mass in left forehead causing downwards and outwards displacement of orbit pretherapy. (B) Left lateral view showing protuberant mass in left forehead causing downwards displacement of orbit pretherapy. (C and D) Frontal and left lateral views showing resolution of forehead swelling postchemotherapy. Sahu KK, et al. BMJ Case Rep 2015. doi:10.1136/bcr-2015-210759 1 Images in on 26 August 2021 by guest. Protected by copyright. http://casereports.bmj.com/ BMJ Case Reports: first published as 10.1136/bcr-2015-210759 on 4 June 2015. Downloaded from

Images in Macrofocal multiple myeloma with frontal plasmacytoma · outcome.1 Macrofocal multiple myeloma is a dis-tinct entity (with multiple lytic lesions and no bone marrow involvement)

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Images in Macrofocal multiple myeloma with frontal plasmacytoma · outcome.1 Macrofocal multiple myeloma is a dis-tinct entity (with multiple lytic lesions and no bone marrow involvement)

Macrofocal multiple myeloma with frontalplasmacytomaKamal Kant Sahu,1 Pramod DA Kumar,2 Uday Yanamandra,1,3 Pankaj Malhotra1

1Departments of Hematologyand Internal Medicine, PostGraduate Institute of MedicalEducation and Research,Chandigarh, India2Department of InternalMedicine, Post GraduateInstitue of Medical Educationand Research, Chandigarh,India3Department of InternalMedicine, Armed ForcesMedical College, Pune,Maharashtra, India

Correspondence toDr Uday Yanamandra,[email protected]

Accepted 8 May 2015

To cite: Sahu KK,Kumar PDA, Yanamandra U,et al. BMJ Case RepPublished online: [pleaseinclude Day Month Year]doi:10.1136/bcr-2015-210759

DESCRIPTIONA 27-year-old man presented with a 5-monthhistory of left-sided forehead swelling. The patienthad no other symptoms. Examination was unre-markable except for pallor and swelling of the leftfrontal bone displacing the orbit in a downwardand outward direction (figure 1A, B).The patient had normochromic normocytic

anaemia (haemoglobin 8.7 g/dL) with normal totalleucocyte count (3900/mL) and platelet count(200 000/mL). His renal parameters (urea 29 mg/dL,creatine 0.66 mg/dL) as well as serum calcium level(9.2 mg/dL) were normal. Positron emission tomog-raphy CT showed intense fluorodeoxyglucose uptakein left frontal region accompanied by multiple lyticlesions (figure 2A–D). Fine-needle aspiration fromforehead swelling was suggestive of plasmacytoma(figure 3). Bone marrow showed 8% plasma cells.There was no paraproteinaemia, based on normalserum/urine protein electrophoresis and serum

immunofixation. A serum β2-microglobulin (2.1 mg/L) and serum free light chain study was normal.Diagnosis of macrofocal multiple myeloma (ISS-I,C-R-A+B+) was made.The patient received six cycles of chemotherapy

(dexamethasone 40 mg weekly, thalidomide100 mg daily) followed by thalidomide mainten-ance owing to financial constraints and non-affordability for autologous haematopoietic stemcell transplantation. His forehead swelling disap-peared following three cycles (figure 1C, D).Presence of extramedullary plasmacytoma (com-

monly involving soft tissue, lungs, pleura, genito-urinary system and skull) is associated with pooroutcome.1 Macrofocal multiple myeloma is a dis-tinct entity (with multiple lytic lesions and no bonemarrow involvement) with superior rates of sur-vival.2 Orbital plasmacytomas are treated differentlyby various authors, using radiotherapy, local dexa-methasone injection or systemic chemotherapy.3

Figure 1 (A) Frontal view showing protuberant mass in left forehead causing downwards and outwardsdisplacement of orbit pretherapy. (B) Left lateral view showing protuberant mass in left forehead causing downwardsdisplacement of orbit pretherapy. (C and D) Frontal and left lateral views showing resolution of forehead swellingpostchemotherapy.

Sahu KK, et al. BMJ Case Rep 2015. doi:10.1136/bcr-2015-210759 1

Images in… on 26 A

ugust 2021 by guest. Protected by copyright.

http://casereports.bmj.com

/B

MJ C

ase Reports: first published as 10.1136/bcr-2015-210759 on 4 June 2015. D

ownloaded from

Page 2: Images in Macrofocal multiple myeloma with frontal plasmacytoma · outcome.1 Macrofocal multiple myeloma is a dis-tinct entity (with multiple lytic lesions and no bone marrow involvement)

Learning points

▸ Macrofocal multiple myelomas have improved rates ofsurvival owing to low tumour burden despite multiple lyticbone lesions.

▸ Macrofocal multiple myelomas have higher response rates toprimary treatment.

▸ Patients are treated either with radiotherapy orchemotherapy in extramedullary plasmacytomas andmacrofocal multiple myeloma.

Acknowledgements The authors would like to acknowledge the cooperationextended by Professor BR Mittal and the Nuclear Medicine Department.

Contributors All authors were actively involved in the management of the patientat various stages of his illness. UY and KKS were involved in manuscript preparation.

Competing interests None declared.

Patient consent Obtained.

Provenance and peer review Not commissioned; externally peer reviewed.

REFERENCES1 Gozzetti A, Marchini E, Banchi B, et al. Extramedullary multifocal plasmacytoma

relapse in multiple myeloma. Leuk Res 2012;36:e34–6.2 Dimopoulos MA, Pouli A, Anagnostopoulos A, et al. Macrofocal multiple myeloma in

young patients: a distinct entity with favorable prognosis. Leuk Lymphoma2006;47:1553–6.

3 Painter SL, Dickens E, Elston JS. Isolated extraocular muscle infiltration withplasmacytoma treated with localized injection of dexamethasone. J Neuroophthalmol2015;35:168–70.

Figure 2 (A) X-ray of the skull (Water’s view) showing increased scalloping of frontal sinus of left as compared with right side (pretherapy). (B–D)Positron emission tomography CT showing intense fluorodeoxyglucose uptake in the heterogeneously enhancing soft tissue mass lesion in the leftfrontal, manubrium sterni, multiple vertebral bones and right head of the tibia (pretherapy).

Figure 3 Fine-needle aspiration from the forehead swelling showinginfiltration by plasma cells suggestive of plasmacytoma (H&E staining—oil immersion—×1000).

2 Sahu KK, et al. BMJ Case Rep 2015. doi:10.1136/bcr-2015-210759

Images in… on 26 A

ugust 2021 by guest. Protected by copyright.

http://casereports.bmj.com

/B

MJ C

ase Reports: first published as 10.1136/bcr-2015-210759 on 4 June 2015. D

ownloaded from

Page 3: Images in Macrofocal multiple myeloma with frontal plasmacytoma · outcome.1 Macrofocal multiple myeloma is a dis-tinct entity (with multiple lytic lesions and no bone marrow involvement)

Copyright 2015 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visithttp://group.bmj.com/group/rights-licensing/permissions.BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.

Become a Fellow of BMJ Case Reports today and you can:▸ Submit as many cases as you like▸ Enjoy fast sympathetic peer review and rapid publication of accepted articles▸ Access all the published articles▸ Re-use any of the published material for personal use and teaching without further permission

For information on Institutional Fellowships contact [email protected]

Visit casereports.bmj.com for more articles like this and to become a Fellow

Sahu KK, et al. BMJ Case Rep 2015. doi:10.1136/bcr-2015-210759 3

Images in… on 26 A

ugust 2021 by guest. Protected by copyright.

http://casereports.bmj.com

/B

MJ C

ase Reports: first published as 10.1136/bcr-2015-210759 on 4 June 2015. D

ownloaded from